The FDA is considering authorizing Pfizer’s COVID vaccine booster shot for those who are high-risk or 65 and older. It comes as the Delta variant surge appears to be peaking nationally, according to researchers advising the CDC. Nancy Chen has the latest. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.